Overview: A Georgia man who suffered from three gastrointestinal hemorrhages after taking the blood thinner Plavix has decided to pursue litigation against the drug’s manufacturer. Parker Waichman LLP, a national personal injury firm, has filed a lawsuit on behalf of the man alleging that the drugmakers knew about the risk of bleeding but failed to warn consumers.
Product: Plavix (clopidogrel)
Manufacturer: Sanofi-Aventis, Bristol-Myers Squibb Co.
Side Effects & Complications
· Cerebral hemorrhage
· Thrombotic Thrombocytopenic Purpura (TTP)
· Gastrointestinal bleeding
· Internal bleeding
· Bone marrow damage
· Heart attack
According to a press release by Parker Waichman, the lawsuit is being filed against Bristol-Myers Squibb Company, Sanofi-Aventis U.S., L.L.C., Sanofi US Services Inc., and Sanofi-Synthelabo, Inc. Allegedly, these Defendants were aware that Plavix increased the risk of major bleeding, but did not adequately warn consumers of the medical community. The suit claims that these actions were conducted out of financial interests, and with complete disregard for the Plaintiff’s health and well-being.
The Plaintiff is a man from Muscogee, Georgia who took Plavix for approximately 14 years, from 1998 to 2012. He endured three bouts of gastrointestinal hemorrhaging during this time period, the most recent of which occurred last November. The Plaintiff alleges that Plavix caused the bleeding. Furthermore, his injuries have allegedly led to additional adverse consequences in the form of medical expenses, physical and mental pain and suffering and loss of enjoyment of life.
Parker Waichman filed the suit on Septemer 28th in the Supreme Court of New York, County of New York.
Plavix Bleeding Risks
Plavix is a medication used to prevent blood clot, stroke and heart attack in patients who have had a history of these conditions or at high risk of them. According to the lawsuit, Plavix has a higher risk of bleeding compared to alternative therapies, particularly Aspirin. A recent study published in the New England Journal of Medicine, for instance, found that patients taking Aspirin with Plavix had twice the risk of major bleeding compared to those taking Aspirin alone. Furthermore, researchers noted that the rate of a repeat stroke among these patients was comparable, meaning that Plavix and Aspirin were not more effect that just Aspirin at preventing such events.